<DOC>
	<DOCNO>NCT01320553</DOCNO>
	<brief_summary>The present study test administration different concentration 1334H eyedrop effective treatment allergic conjunctivitis people 10 yrs age older .</brief_summary>
	<brief_title>Effect Different Concentrations SPARC1102 Allergic Conjunctivitis</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<criteria>Signed informed consent form HIPAA document Willing able comply study procedure Be least 10 year age time enrollment LogMar 0.7 better , eye History ocular allergy , positive skin ocular allergic reaction allergens A negative urine pregnancy test female childbearing potential must use adequate birth control throughout study period know contraindication sensitivity use study medication ( ) component ; ocular condition , opinion investigator , could affect subject 's safety trial parameter ( include limit narrow angle glaucoma , clinically significant blepharitis , follicular conjunctivitis , iritis , pterygium diagnosis dry eye ) ; current diagnosis history open angle glaucoma ocular hypertension ; ocular surgical intervention within three ( 3 ) month prior Visit 1 study and/or history refractive surgery within past 6 month ; know history retinal detachment , diabetic retinopathy , progressive retinal disease ; presence active ocular infection ( bacterial , viral fungal ) , positive history ocular herpetic infection , preauricular lymphadenopathy visit ; manifest sign symptom clinically active allergic conjunctivitis either eye screening study use investigational drug device within 30 day study concurrently enrol another investigational drug device study within 30 day study</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>